Literature DB >> 20533792

Marvelous medicines and dangerous drugs: the representation of prescription medicine in the UK newsprint media.

Helen Prosser1.   

Abstract

Using discourse analysis, this study examines the representation of prescription medicines in the UK newsprint media and, specifically, how the meaning and function of medicines are constructed. At the same time, it examines the extent to which the newsprint media represents a resource for health information, and considers how it may encourage or challenge faith in modern medicine and medical authority. As such, it extends analysis around concepts such as the informed patient and examines the representation of patients and doctors and the extent to which patient-doctor identities promoted in the newsprint media reflect a shift away from paternalism to negotiated encounters. Findings show the media constructs a discrete, contradictory, and frequently oversimplified set of characterizations about medicine. Moreover, it discursively constructs realities that justify and sustain medial dominance. Ideological paradigms in discourse assign patients as passive and disempowered while simultaneously privileging "expert" knowledge. This constructs a reality that marginalizes patients' participation in decision-making.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533792     DOI: 10.1177/0963662508094100

Source DB:  PubMed          Journal:  Public Underst Sci        ISSN: 0963-6625


  10 in total

1.  Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities.

Authors:  Jill A Fisher; Marci D Cottingham; Corey A Kalbaugh
Journal:  Soc Sci Med       Date:  2014-08-19       Impact factor: 4.634

2.  Medicines as Common Commodities or Powerful Potions? What Makes Medicines Reusable in People's Eyes.

Authors:  Monica Chauhan; Hamza Alhamad; Rachel McCrindle; Terence K L Hui; R Simon Sherratt; Parastou Donyai
Journal:  Pharmacy (Basel)       Date:  2021-04-20

3.  Pharmacogenetics and the print media: what is the public told?

Authors:  Basima Almomani; Ahmed F Hawwa; Nicola A Goodfellow; Jeffrey S Millership; James C McElnay
Journal:  BMC Med Genet       Date:  2015-05-09       Impact factor: 2.103

4.  A content analysis of the representation of statins in the British newsprint media.

Authors:  Julia Chisnell; Tom Marshall; Chris Hyde; Zhivko Zhelev; Lora E Fleming
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

5.  Between facts and ambiguity: Discourses on medical cannabis in Swedish newspapers.

Authors:  Ernesto Abalo
Journal:  Nordisk Alkohol Nark       Date:  2021-04-12

6.  Potential of UK and US newspapers for shaping patients' knowledge and perceptions about antidiabetic medicines: a content analysis.

Authors:  Nadia Farhanah Syafhan; Gaoyun Chen; Carole Parsons; James C McElnay
Journal:  J Pharm Policy Pract       Date:  2022-10-15

7.  Regulation of antibiotic sales in Mexico: an analysis of printed media coverage and stakeholder participation.

Authors:  Anahí Dreser; Edna Vázquez-Vélez; Sandra Treviño; Veronika J Wirtz
Journal:  BMC Public Health       Date:  2012-12-06       Impact factor: 3.295

8.  What the newspapers say about medication adherence: a content analysis.

Authors:  Nicola A Goodfellow; Basima A Almomani; Ahmed F Hawwa; James C McElnay
Journal:  BMC Public Health       Date:  2013-10-02       Impact factor: 3.295

9.  Medicines and the media: news reports of medicines recommended for government reimbursement in Australia.

Authors:  Jane Robertson; Emily J Walkom; Marc D Bevan; David A Newby
Journal:  BMC Public Health       Date:  2013-05-21       Impact factor: 3.295

10.  Disease awareness campaigns in printed and online media in Latvia: cross-sectional study on consistency with WHO ethical criteria for medicinal drug promotion and European standards.

Authors:  Teresa Leonardo Alves; Elita Poplavska; Signe Mezinska; Ieva Salmane-Kulikovska; Liga Andersone; Aukje K Mantel-Teeuwisse; Barbara Mintzes
Journal:  BMC Public Health       Date:  2018-11-28       Impact factor: 3.295

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.